RCT-201

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRCT-201
Drug Alias NameCFTR gene modulator (ReCode Therapeutics/CFFT Lab/UT Southwestern Medical Center/University of Bristol/Johns Hopkins School of Medicine/University of North Carolina/University of Porto)RCT-201
ClassificationBiologics
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulatorsRNA modulators
TargetsRibonucleic AcidCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecode Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of North Carolina, GreensboroUniversity of Texas Southwestern Medical CenterUniversidade do Porto +[7] 
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A